Research ArticleClinical Studies
Serum Prognostic Factors of Androgen-deprivation Therapy Among Japanese Men With De Novo Metastatic Prostate Cancer
TAKESHI KOBAYASHI, RYO NAMITOME, YU HIRATA, MASAKI SHIOTA, KENJIRO IMADA, EIJI KASHIWAGI, ARIO TAKEUCHI, JUNICHI INOKUCHI, KATSUNORI TATSUGAMI and MASATOSHI ETO
Anticancer Research June 2019, 39 (6) 3191-3195; DOI: https://doi.org/10.21873/anticanres.13457
TAKESHI KOBAYASHI
Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
RYO NAMITOME
Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
YU HIRATA
Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
MASAKI SHIOTA
Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
KENJIRO IMADA
Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
EIJI KASHIWAGI
Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
ARIO TAKEUCHI
Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
JUNICHI INOKUCHI
Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
KATSUNORI TATSUGAMI
Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
MASATOSHI ETO
Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
In this issue
Serum Prognostic Factors of Androgen-deprivation Therapy Among Japanese Men With De Novo Metastatic Prostate Cancer
TAKESHI KOBAYASHI, RYO NAMITOME, YU HIRATA, MASAKI SHIOTA, KENJIRO IMADA, EIJI KASHIWAGI, ARIO TAKEUCHI, JUNICHI INOKUCHI, KATSUNORI TATSUGAMI, MASATOSHI ETO
Anticancer Research Jun 2019, 39 (6) 3191-3195; DOI: 10.21873/anticanres.13457
Serum Prognostic Factors of Androgen-deprivation Therapy Among Japanese Men With De Novo Metastatic Prostate Cancer
TAKESHI KOBAYASHI, RYO NAMITOME, YU HIRATA, MASAKI SHIOTA, KENJIRO IMADA, EIJI KASHIWAGI, ARIO TAKEUCHI, JUNICHI INOKUCHI, KATSUNORI TATSUGAMI, MASATOSHI ETO
Anticancer Research Jun 2019, 39 (6) 3191-3195; DOI: 10.21873/anticanres.13457
Jump to section
Related Articles
- No related articles found.
Cited By...
- Is it Necessary to Treat all Metastatic Prostate Cancer With Upfront Androgen Receptor Axis-targeted Agents?
- Prognostic Significance of 3-Month Prostate-specific Antigen Level Following Androgen-deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer
- Lactate Dehydrogenase Is a Serum Prognostic Factor in Clinically Regional Lymph Node-positive Prostate Cancer